Identifying Persons in Need of Weight-loss Treatment: Evaluation of Potential Treatment Algorithms Caitlin Mason School of Physical and Health Education.

Slides:



Advertisements
Similar presentations
Inactive lifestyle. Risk!! Inactive life style = the same risk as hypertension Inactive life style = the same risk as cholesterol Inactive life style.
Advertisements

Body mass index and waist circumference as predictors of mortality among older Singaporeans Authors: Angelique Chan, Chetna Malhotra, Rahul Malhotra, Truls.
Assessment of Overweight and Obesity and the Need for Weight Loss Dr. David L. Gee FCSN/PE 446 Nutrition, Weight Control & Exercise.
Definitions Body Mass Index (BMI) describes relative weight for height: weight (kg)/height (m 2 ) Overweight = 25–29.9 BMI Obesity = >30 BMI.
Change in Abdominal Obesity & Risk of Coronary Calcification Siamak Sabour, MD, MSc, DSc, PhD, Postdoc Clinical Epidemiologist Persian International Epidemiology.
EUROACTION: Changes in diet and physical activity over one year in a family based preventive cardiology programme in hospital and general practice Jennifer.
10 Points to Remember for the Management of Overweight and Obesity in Adults Management of Overweight and Obesity in Adults Summary Prepared by Elizabeth.
Pathophsiology of Metabolism. Obesity What Is Obesity? Obesity means having too much body fat.
Cardio-Metabolic Syndrome Guidelines on Education, Detection and Early Treatment  Heval Mohamed Kelli, PGY-2 Emory Internal Medicine Residency no conflict.
U.S. Dept of Health and Human Services. National High Blood Pressure Education Program. Seventh Report of Joint National Committee on Prevention, Detection,
SUPERSIZED NATION By Jennifer Ericksen August 24, 2007.
OBESITY and CHD Nathan Wong. OBESITY AHA and NIH have recognized obesity as a major modifiable risk factor for CHD Obesity is a risk factor for development.
The Relationship Between Weight Status During Early Adulthood And Successful Aging In Elderly Canadian Males: The Manitoba Follow-up Study Dennis J. Bayomi,
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
Prescreening ä To optimize safety ä To permit the development of a sound and effective exercise prescription.
Body Weight and Mortality: New Population Based Evidences Body Weight and Mortality: New Population Based Evidences Dongfeng Gu, MD Dongfeng Gu, MD Fu.
What is Body Mass Index (BMI) What is Body Mass Index (BMI)
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
LIFESTYLE MODIFICATIONS FOR PREVENTING HEART DISEASE [e.g. HEART ATTACKS] [ primary prevention of coronary artery disease ] DR S. SAHAI MD [Med.], DM [Card]
השמנת יתר חמד " ע פרופ ' ארדון רובינשטין.
C-REACTIVE PROTEIN, FIBRINOGEN, AND CARDIOVASCULAR DISEASE PREDICTION By Patrick Whitledge PA-S2 South University Physician Assistant Program.
Glucose Levels and Risk of Dementia Presented by - Anas Kabaha, MD Sheba medical center Sheba medical center August 8,2013.
The United States & Heart Disease Presented today by; Matt Lorup, Keith Arline, & Nick Knight.
Body Mass Index, Weight Change and Death in an Older Hypertensive Population: The SHEP Study Grant W Somes Stephen B Kritchevsky Marco Pahor Ronald I Shorr.
HEALTHY EATING And LIVING Kenneth E. Nixon MD. Problem Overweight and Obesity 97 million adults are overweight or obese Medical Problems Associated with.
{ A Novel Tool for Cardiovascular Risk Screening in the Ambulatory Setting Guideline-Based CPRS Dialog Adam Simons MD.
Emily O’Brien, Emil Fosbol, Andrew Peng, Karen Alexander, Matthew Roe, Eric Peterson The Obesity Paradox: The Importance for Long-term Outcomes in Non-ST-Elevation.
Results of Monotherapy in ALLHAT: On-treatment Analyses ALLHAT Outcomes for participants who received no step-up drugs.
METABOLIC Syndrome: a Global Perspective
1 Presenter Disclosure Information FINANCIAL DISCLOSURE: DSMB’s: Merck, Takeda Barry R. Davis, MD, PhD Clinical Outcomes in Participants with Dysmetabolic.
Harmonizing Cardiovascular Risk Intervention Guidelines in Canada – The C-CHANGE Initiative February 6, 2013 Montreal, Quebec Harmonizing Cardiovascular.
LIFESTYLE INTERVENTION You CAN’T change where you came from…….. You CAN change where you are going……
Low level of high density lipoprotein cholesterol in children of patients with premature coronary heart disease. Relation to own and parental characteristics.
Improving the Quality of Physical Health Checks
The effects of initial and subsequent adiposity status on diabetes mellitus Speaker: Qingtao Meng. MD West China hospital, Chendu, China.
Aging and Obesity Claire Zizza Tenth Annual Diabetes and Obesity Conference April 19, 2011.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Medical Management of obesity Perinatal ANGELS Conference Feb 17, 2005 Philip A. Kern.
Anthropometrics in Obesity Robert Kushner, MD Northwestern University Feinberg School of Medicine.
Metabolic Syndrome Yusra Mir, MD Zunairah Syed, MD Harjagjit Maan, MD.
1. Relation between dietary macronutrient and fiber intake with metabolic syndrome in Tehranian adults: Tehran Lipid and Glucose Study Hosseinpour S,
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
HS499 Bachelor’s Capstone Week 6 Seminar Research Analysis on Community Health.
VA/DoD 2006 Clinical Practice Guideline For Screening and Management of Overweight and Obesity Guideline Summary: Key Elements.
10 Points to Remember on the Assessment of Cardiovascular RiskAssessment of Cardiovascular Risk Summary Prepared by Melvyn Rubenfire, MD.
Illinois State University Exercise and Body Composition Relationships of Total and Regional Body Composition to Morbidity and Mortality.
Organizational criteria for Metabolic Syndrome National Cholesterol Education Program Adult Treatment Panel III World Health OrganizationAmerican Association.
Diabetes National Diabetes Control Programme
Ethnic variation in the contribution of Cardiorespiratory fitness and muscular strength to diabetes: crossectional study of 68,116 UK Biobank participants.
Pai JK et al. N Engl J Med 2004; 351: Relative CHD risk by increasing baseline CRP plasma levels,* relative to CRP
High level of low density lipoprotein cholesterol in adult children of patients with premature coronary heart disease: relation to own and parental characteristics.
Association between Systolic Blood Pressure and Congestive Heart Failure Complication among Hypertensive and Diabetic Hypertensive Patients Mrs. Sutheera.
Promoting Physical Activity in Jamaica Dr Deanna Ashley.
Low Fitness as a Predictor of Morbidity and Mortality
END Obesity Dr Gul Bano © S Nussey. What is obesity?
Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council
Baseline Prevalence of Metabolic Syndrome and Individual Components Among 4258 Older Adults Dariush Mozaffarian, et al. Arch Intern Med. 2008;168:
Diabetes Health intelligence Jon Walker Advanced public health analyst Surrey County Council
Monitoring Physical Health Stephen R. Marder, M.D. Professor, Semel Institute for Neuroscience and Human Behavior at UCLA Director, VA VISN 22 Mental Illness.
Geographic and Demographic Variation in the Prevalence of the Metabolic Syndrome in Canada Chris Ardern School of Physical and Health Education Queen’s.
Anthropometric Predictors of Type 2 Diabetes Among White and Black Adults Dale S. Hardy, PhD, RD, Devita T. Stallings, PhD, RN, Jane T. Garvin, PhD, RN,
Case 1: Elevated LDL-C in a Young Adult. Page 2 of 10 *DALY; disability-adjusted life years Routine checkup:  Age:33 years  Sex: male  Status: Except.
The short term effects of metabolic syndrome and its components on all-cause-cause mortality-the Taipei Elderly Health Examination Cohort Wen-Liang Liu.
Cardiovascular Risk: A global perspective
Noncommunicable Diseases Surveillance in Egypt
Peak oxygen uptake and prevalence of cardiovascular disease risk factors in breast cancer survivors Lahart1, I.M., Metsios1, G.S., Nevill1, A.M., Kitas1,2,
Results Methods Conclusions:
Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults Risks and Assessment NHLBI Obesity Education.
Bonnie Sanderson, PhD, RN
The complications of obesity according to the values of BMI and waist circumference in an obese population of Tangier Nadia HAMJANE 1, Fatiha BENYAHYA1,2,
Presentation transcript:

Identifying Persons in Need of Weight-loss Treatment: Evaluation of Potential Treatment Algorithms Caitlin Mason School of Physical and Health Education Queen’s University, Kingston, ON

 Obesity is an increasingly significant Canadian health issue: 59.2% of adults are overweight or obese (CCHS, 2004) 1 in 10 premature deaths can be attributed to overweight and obesity (Katzmarzyk & Ardern, 2004) associated with substantial health care costs (~$4.3 billion annually) (Katzmarzyk & Janssen, 2004) Background

 Screening for overweight and obesity is now considered an integral part of routine medical assessments (Douketis et al., 2005) Canadian Guidelines for Body Weight Classification in Adults  In 2003, Health Canada published the Canadian Guidelines for Body Weight Classification in Adults  Canadian guidelines do not include recommendations for weight loss interventions/treatment BMIWCCVD risk factors  In 1998, the U.S. NIH Obesity Education Initiative Expert Panel proposed a treatment algorithm that uses measures of BMI (kg/m 2 ), WC (cm), and CVD risk factors to identify patients for weight loss treatment.

Measure height, weight and waist circumference Calculate BMI BMI  25 or Waist >88 cm (F) >102 cm (M) Assess Risk Factors BMI  30 OR [BMI or waist >88 cm (F) >102 cm (M) AND  2 risk factors] Treatment Options Lifestyle therapy Pharmacotherapy Weight loss surgery RISK FACTORS Smoking Hypertension High LDL-C Low HDL-C Previous coronary event Diabetes  45y (M)  55 y (F) Does patient want to lose weight? Educate/ Reinforce No Yes Patient Encounter No

 Quantify the proportion of Canadians meeting the criteria of the existing NIH algorithm and derivative algorithms for weight loss treatment Purpose Study 1: C Mason & PT Katzmarzyk. Application of obesity treatment algorithms to the Canadian population. Euro J Clin Nutr 2005;59:

The following four treatment algorithms were compared: A.NIH algorithm: BMI>30 OR {[BMI OR WC >88cm(F), >102cm(M)] AND  2 CVD risk factors} B.BMI alone: BMI>30 OR {BMI AND  2 CVD risk factors} C. WC alone (single cutoff): WC >88cm (F) >102cm(M) AND  2 CVD risk factors D.WC alone (tiered cutoffs): WC >88cm(F), >102cm(M) OR {WC >80cm(F), >94cm(M)] AND  2 CVD risk factors}

 Canadian Heart Health Surveys (CHHS) Waist circumference measures made in only five central provinces, thus analysis limited to: Alberta, Saskatchewan, Manitoba, Ontario, and Quebec Methods

Participants were assigned to a high CVD risk status based on presence of 2 or more CVD risk factors, including: Current smoking Hypertension ( SBP  140 mmHg, DBP  90 mmHg ) High LDL-C (>4.13 mmol/L ) Low HDL-C (<0.90 mmol/L ) Self-report diabetes Age (M:  45 yrs, F:  55 yrs ) Previous cardiovascular event  2 CVD RISK FACTORS  Family history was excluded (not collected in all provinces). Subset analysis confirmed this did not make a difference (23.6% vs. 23.9%) in the proportion of subjects recommended treatment.

ALGORITHM Overall (n=7501) Men (n=3678) Women (n=3823) NIH algorithm: BMI  30 OR {[BMI OR WC >88cm(F), >102cm(M)] AND  2 CVD risk factors} BMI alone algorithm: BMI  30 OR {BMI AND  2 CVD risk factors} WC algorithm (single cutoff): WC >88cm (F) >102cm(M) AND  2 CVD risk factors WC algorithm (tiered cutoffs): WC >88cm(F), >102cm(M) OR {[WC >80cm(F), >94cm(M)] AND  2 CVD risk factors} Proportion of CHHS sample meeting the criteria for each of 4 algorithms for weight-loss treatment

NIH algorithm BMI alone algorithm WC algorithm (single cut-off) WC algorithm (tiered cut-off) 6.7% 18.2% 5.8% 0.01% 3.8% Proportion of CHHS sample meeting the criteria for each of 4 algorithms for weight-loss treatment

 Approximately 1 in 4 Canadians would be eligible for weight loss treatment  Within the context of the NIH algorithm, the utility of WC appears constrained by the thresholds used Implications

Study 2: Mason C, PT Katzmarzyk & SN Blair. Eligibility for obesity treatment and risk of mortality in men. Obes Res 2005; In press.  Evaluate the utility of the NIH algorithm in identifying men at increased risk of premature mortality  Examine the effects of physical fitness on the risk of mortality associated with each outcome of the algorithm Purpose

Subjects 18,666 men from the Aerobics Center Longitudinal Study (ACLS), Dallas, TX aged years (mean = 42.9  9.2 yrs) clinical evaluations between 1979 and 1995 Methods

Measures Physical exam: Height Weight Waist circumference Resting blood pressure Fasting blood sample Personal & family medical history Health habits questionnaire Cardiorespiratory fitness: maximal treadmill exercise test categorized as fit or unfit based on age-specific maximal METs lowest quintile (20%) classified as unfit, upper four quintiles(80%) as fit

Participants were assigned to a high CVD risk status based on presence of 2 or more CVD risk factors, including: Current smoking Hypertension ( SBP  140 mmHg, DBP  90 mmHg ) High LDL-C (>4.13 mmol/L ) Low HDL-C (<0.90 mmol/L ) Elevated fasting blood glucose (  6.1 mmol/L ) Diabetes Age (  45 yrs ) Previous cardiovascular event Family history of premature cardiovascular disease  2 CVD RISK FACTORS

Mortality Surveillance Linked with the NCHS National Death Index Coded according to ICD-9 codes CVD mortality defined as codes 390 to Until death or December 31 st, 1996 Analysis Cox proportional hazards regression Adjusted for age and year of examination

Relative risks of CVD mortality by NIH risk classification CVD Mortality Hazard Ratio Normal Weight Overweight <2 CVD risk factors Overweight  2 CVD risk factors Obese <2 CVD risk factors Obese  2 CVD risk factors 1.0 [reference] 0.72 [ ] 1.67 [ ] 1.69 [ ] 3.31 [ ] Maintain weight Weight loss treatment 1.0 [reference] 2.16 [ ] 1.37 [ ] 1.0 [reference] 0.60 [ ] 1.14 [ ] 0.83 [ ] 1.50 [ ] CRF adjusted

Relative risk of all-cause and CVD mortality according to NIH criteria for weight loss, by fitness Maintain weight Weight loss Treatment Maintain weight Weight loss Treatment * p < 0.05 from fit men who would be recommended to maintain current body weight * * * * All-Cause CVD R R

Conclusions The NIH obesity treatment algorithm is useful in identifying men at increased risk of premature mortality Risk of obesity-related mortality is significantly attenuated by cardiorespiratory fitness Including an assessment of fitness would help improve risk stratification among all groups of patients

Taken together… Provide support for the NIH algorithm as a valuable clinical tool Supports the promotion of physical activity as a valuable prevention strategy Further research needed to discern the most appropriate anthropometric cut-offs

The Canadian Heart Health Surveys Follow-up Study is a New Emerging Team, funded by the Canadian Institutes for Health Research and the Heart and Stroke Foundation of Canada